CDJEV Japanese Encephalitis Vaccine Introduction Training Modules for
- Slides: 10
CD-JEV Japanese Encephalitis Vaccine Introduction Training Modules for Health Care Workers Module 3 JE vaccine eligibility
Learning objectives l At the end of the module, the participant will be able to: – Describe the recommended immunization schedule for CD-JEV. – Describe when a child is eligible for CD-JEV and when he/she is not eligible. – Describe the contraindications for vaccination. l Duration: – 15 minutes 2 | JE vaccine eligibility, Module 3 | November 2020
Key issues 1 What is the schedule for CD-JEV? 2 What are the contraindications for vaccination? 3 | JE vaccine eligibility, Module 3 | November 2020
What is the CD-JEV schedule? l CD-JEV can be given in a single dose from 8 months of age or older, or to children or adults who intend to enter endemic areas from non-endemic areas. JE vaccine Birth 8 months 4 | JE vaccine eligibility, Module 3 | November 2020
CD-JEV eligibility l Children 8 months of age or older. l Adults travelling to endemic areas. l A child who has received a different JE vaccine in the past (e. g. , mouse brain-derived JE vaccine), even more than once, can be vaccinated with CD-JEV. 5 | JE vaccine eligibility, Module 3 | November 2020
Can CD-JEV be given at the same time as other childhood vaccines? l According to WHO, it is acceptable to give CD-JEV with other vaccines, such as measles and measles-rubella. No safety concerns have been identified in co-administration. l The preferred time to administer CD-JEV to children in JEendemic areas is: – Close to the earliest recommended age (for maximum protection) – During other routine immunizations (for ease of administration) 6 | JE vaccine eligibility, Module 3 | November 2020
Precautions and contraindications (1/2) Mild illness, such as an upper respiratory tract infection, is NOT a contraindication. If a recipient has a mild illness, it is okay to give them CD-JEV. 7 | JE vaccine eligibility, Module 3 | November 2020
Precautions and contraindications (2/2) ● A very severe adverse reaction or a severe hypersensitivity reaction (anaphylaxis) to a prior dose of CD-JEV, or to any vaccine component (e. g. , gelatin, gentamicin, kanamycin). ● Fever higher than 38. 5⁰C. Vaccination should be postponed an appointment should be made for vaccination as soon as possible after the fever settles. ● Immunosuppression (due to disease or medication) or having the signs and symptoms of AIDS. ● Pregnant and lactating women: If the JE risk is sufficient to warrant vaccination of pregnant women, inactivated Vero cell-derived vaccines should be used preferentially over CD-JEV. 8 | JE vaccine eligibility, Module 3 | November 2020
Key messages ● CD-JEV should be given in a single dose at 8 months of age or older. ● Vaccination should be postponed when a fever is higher than 38. 5⁰C and not given if there has been a prior severe hypersensitivity reaction to any vaccine component. ● It is safe to give CD-JEV to a patient with a mild illness. 9 | JE vaccine eligibility, Module 3 | November 2020
End of module Thank you for your attention! Ø Next is Module 4: JE vaccine administration 10 | JE vaccine eligibility, Module 3 | November 2020
